New registry tracks pregnancy risks in rare genetic disorders
NCT ID NCT06160310
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects information from pregnant women with Tuberous Sclerosis Complex (TSC) or Lymphangioleiomyomatosis (LAM) and their babies. Researchers will monitor medication use, side effects, pregnancy complications, and mental health after birth. The goal is to better understand how these conditions affect pregnancy and how to improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHANGIOLEIOMYOMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain imaging may unlock early clues to autism in tuberous sclerosis
- Play therapy may boost social skills in infants with tuberous sclerosis — a trial puts it to the test
- New daily pill aims to tame stubborn seizures in tuberous sclerosis
- New italian model aims to ease epilepsy care transition for teens
- Massive TSC data and tissue bank opens to researchers
- Walking analysis sheds light on rare genetic disorders